Adaption and Innovation

article image

Building new things often calls for flexibility and creative thinking. This is certainly the case when it comes to a company leveraging available medtech regulatory and reimbursement pathways.

I was struck in discussions at the Wilson Sonsini Goodrich & Rosati Medical Device Conference last month (where we unveiled the inaugural issue of MTS Market Pathways) by the diversity of challenges firms face and the need to adapt to circumstances. Solutions to problems can be as complex as designing a novel clinical trial protocol to respond to regulators’ questions, or as seemingly simple as changing a product’s name to support a more tailored and favorable reimbursement policy.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: